Akoya Biosciences (AKYA) News Today $1.06 +0.01 (+0.95%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AKYA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $1.08 by Analysts at Canaccord Genuity GroupMay 21 at 1:54 AM | americanbankingnews.comAkoya Biosciences (NASDAQ:AKYA) Releases Earnings Results, Misses Expectations By $0.03 EPSAkoya Biosciences (NASDAQ:AKYA - Get Free Report) announced its earnings results on Monday. The company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by ($0.03). Akoya Biosciences had a negative return on equity of 162.99% and a negative net margin of 66.77%.May 14, 2025 | marketbeat.comAkoya Biosciences Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comAkoya Biosciences (AKYA) to Release Earnings on MondayMay 11, 2025 | americanbankingnews.comAKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYAMay 7, 2025 | businesswire.comAkoya Biosciences (AKYA) to Release Quarterly Earnings on MondayAkoya Biosciences (NASDAQ:AKYA) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-akoya-biosciences-inc-stock/)May 7, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Recommendation of "Hold" by AnalystsShares of Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) have earned a consensus recommendation of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating. The average 12 month price objective aMay 6, 2025 | marketbeat.comCanaccord Genuity Group Cuts Akoya Biosciences (NASDAQ:AKYA) Price Target to $1.80Canaccord Genuity Group cut their price target on Akoya Biosciences from $3.50 to $1.80 and set a "hold" rating for the company in a research note on Tuesday.May 1, 2025 | marketbeat.comAkoya Unveils ADC Breast Cancer Assay, Validates IO60 Spatial Panel At AACR 2025April 26, 2025 | nasdaq.comAkoya expands portfolio with new ADC breast cancer assay at AACR 2025April 25, 2025 | markets.businessinsider.comAkoya Biosciences, Enable Medicine launch single-cell spatial proteomics atlasApril 25, 2025 | markets.businessinsider.comAkoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics AtlasApril 24, 2025 | globenewswire.comAkoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025April 24, 2025 | globenewswire.comAkoya Biosciences, STCC partner on SUPER study for cancer immunophenotypingApril 23, 2025 | markets.businessinsider.comAkoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in SingaporeApril 23, 2025 | globenewswire.comAkoya Biosciences (NASDAQ:AKYA) Price Target Cut to $1.65 by Analysts at Piper SandlerPiper Sandler dropped their target price on Akoya Biosciences from $2.40 to $1.65 and set a "neutral" rating for the company in a report on Monday.April 16, 2025 | marketbeat.comPiper Sandler Remains a Hold on Akoya Biosciences (AKYA)April 15, 2025 | markets.businessinsider.comAkoya Biosciences price target lowered to $1.65 from $2.40 at Piper SandlerApril 15, 2025 | markets.businessinsider.comTikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya BiosciencesApril 14, 2025 | finance.yahoo.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of "Hold" by AnalystsShares of Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) have received a consensus recommendation of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation. The average 12-montApril 10, 2025 | marketbeat.comKent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled AkoyaApril 7, 2025 | uk.finance.yahoo.comKent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled AkoyaApril 7, 2025 | businesswire.comQuanterix: Still Many, Many QuestionsApril 2, 2025 | seekingalpha.comAkoya Biosciences, Team SAMBAI announce selection of PhenoCycler-FusionApril 2, 2025 | markets.businessinsider.comAkoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer InequitiesApril 2, 2025 | globenewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in MarchAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 2,490,000 shares, a decrease of 30.8% from the February 28th total of 3,600,000 shares. Based on an average trading volume of 639,800 shares, the days-to-cover ratio is presently 3.9 days. Approximately 12.0% of the company's shares are sold short.March 30, 2025 | marketbeat.comAkoya Biosciences downgraded to Equal Weight from Overweight at StephensMarch 27, 2025 | markets.businessinsider.comTikvah intends to vote against Quanterix’s proposed merger with AkoyaMarch 26, 2025 | markets.businessinsider.comAkoya Biosciences (NASDAQ:AKYA) Given Equal Weight Rating at StephensStephens restated an "equal weight" rating and issued a $1.80 price target (down from $3.50) on shares of Akoya Biosciences in a report on Tuesday.March 26, 2025 | marketbeat.comStephens & Co. Downgrades Akoya Biosciences (AKYA)March 26, 2025 | msn.comTikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya BiosciencesMarch 24, 2025 | finance.yahoo.comAkoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from StephensStephens reaffirmed an "overweight" rating and issued a $3.50 price target on shares of Akoya Biosciences in a research note on Tuesday.March 19, 2025 | marketbeat.comAkoya Biosciences (AKYA) Receives a Hold from Craig-HallumMarch 19, 2025 | markets.businessinsider.comAkoya Biosciences (NASDAQ:AKYA) Releases Earnings Results, Misses Estimates By $0.02 EPSAkoya Biosciences (NASDAQ:AKYA - Get Free Report) issued its earnings results on Monday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.02). Akoya Biosciences had a negative return on equity of 162.99% and a negative net margin of 66.77%.March 18, 2025 | marketbeat.comKent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings CallMarch 17, 2025 | tmcnet.comAkoya Biosciences reports Q4 EPS (17c), consensus (16c)March 17, 2025 | markets.businessinsider.comAkoya Reports Fourth Quarter of 2024 and Full Year Financial ResultsMarch 17, 2025 | globenewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of "Hold" by BrokeragesShares of Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) have received a consensus rating of "Hold" from the six brokerages that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold rating. The average 12 month price objective among brokersMarch 15, 2025 | marketbeat.comAkoya Biosciences downgraded to Neutral from Overweight at Piper SandlerMarch 5, 2025 | markets.businessinsider.comSVB Wealth LLC Buys Shares of 515,398 Akoya Biosciences, Inc. (NASDAQ:AKYA)SVB Wealth LLC bought a new stake in Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 515,398 shares of the company's stock, valued at approximately $1,180,000. SVB WealtMarch 3, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 60.1% in FebruaryAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 3,250,000 shares, a growth of 60.1% from the January 31st total of 2,030,000 shares. Based on an average daily volume of 666,100 shares, the short-interest ratio is currently 4.9 days. Currently, 15.8% of the shares of the stock are short sold.March 2, 2025 | marketbeat.comAkoya Biosciences (AKYA) Projected to Post Earnings on MondayAkoya Biosciences (NASDAQ:AKYA) will be releasing earnings before the market opens on Monday, March 3.February 24, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Recommendation of "Hold" from AnalystsShares of Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) have been assigned a consensus rating of "Hold" from the seven brokerages that are presently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have issued a buy ratiFebruary 18, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest UpdateAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 2,030,000 shares, a decrease of 6.5% from the January 15th total of 2,170,000 shares. Approximately 9.9% of the company's shares are short sold. Based on an average daily trading volume, of 648,900 shares, the days-to-cover ratio is presently 3.1 days.February 17, 2025 | marketbeat.comAkoya Biosciences unveils strategic product roadmapFebruary 6, 2025 | markets.businessinsider.comAkoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology PanelsFebruary 5, 2025 | globenewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 24.0% in JanuaryAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 2,170,000 shares, a growth of 24.0% from the December 31st total of 1,750,000 shares. Based on an average daily volume of 597,700 shares, the short-interest ratio is presently 3.6 days. Currently, 4.4% of the shares of the stock are short sold.February 1, 2025 | marketbeat.comAkoya Biosciences selects Argonaut Manufacturing as IVD manufacturing partnerJanuary 29, 2025 | markets.businessinsider.comAkoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing PartnerJanuary 28, 2025 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA) and HCA Healthcare (HCA)January 25, 2025 | markets.businessinsider.com Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address AKYA Media Mentions By Week AKYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKYA News Sentiment▼-1.220.65▲Average Medical News Sentiment AKYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKYA Articles This Week▼32▲AKYA Articles Average Week Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QTRX News Today MASS News Today FEIM News Today RPID News Today SEER News Today KEQU News Today NAUT News Today OWLT News Today INTT News Today PRE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKYA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKYA Stock Free AKYA Stock Alerts